Laurent Fischer - 20 Apr 2022 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Role
CEO, President and Director, Director
Signature
Laurent D. Fischer, by /s/ Ron A. Metzger, Attorney-in-Fact
Issuer symbol
ADVM
Transactions as of
20 Apr 2022
Transactions value $
$27,800
Form type
4
Filing time
22 Apr 2022, 17:00:51 UTC
Previous filing
11 Mar 2022
Next filing
06 Jun 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADVM Common Stock Purchase $27.8K +25K +3.39% $1.11 762K 20 Apr 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Price reported is a weighted-average purchase price. The shares were purchased at prices ranging from $1.10 to $1.14. The reporting person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares purchased at each separate price.